Stockreport

Travere Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results

Travere Therapeutics, Inc.  (TVTX) 
PDF SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report fourth quarter and full year 2025 financial results on Thursday, [Read more]